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Inflammasomes elicit host defense inside cells by
activating caspase-1 for cytokine maturation and
cell death. AIM2 and NLRP3 are representative
sensor proteins in two major families of inflamma-
somes. The adaptor protein ASC bridges the sensor
proteins and caspase-1 to form ternary inflamma-
some complexes, achieved through pyrin domain
(PYD) interactions between sensors and ASC and
through caspase activation and recruitment domain
(CARD) interactions between ASC and caspase-1.
We found that PYD and CARD both form filaments.
Activated AIM2 and NLRP3 nucleate PYD filaments
of ASC, which, in turn, cluster the CARD of ASC.
ASC thus nucleates CARD filaments of caspase-1,
leading to proximity-induced activation. Endo-
genous NLRP3 inflammasome is also filamentous.
The cryoelectron microscopy structure of ASCPYD
filament at near-atomic resolution provides a tem-
plate for homo- and hetero-PYD/PYD associations,
as confirmed by structure-guided mutagenesis. We
propose that ASC-dependent inflammasomes in
both families share a unified assembly mechanism
that involves two successive steps of nucleation-
induced polymerization.INTRODUCTION
The immune system provides protection from the environment
and is critically important for multiple aspects of mammalian
biology. It consists of an adaptive component that generates
specific antibodies and cells through clonal selection, and aninnate component that utilizes preformed receptors. Innate
immunity offers the first line of defense against infections
and hazards by directly recognizing conserved pathogen- and
danger-associated molecular patterns (PAMPs and DAMPs)
to alert the immune system (Medzhitov and Janeway, 2000).
Inflammasomes are key components of innate immunity
inside the cell. They are formed in response to PAMPs and
DAMPs and activate inflammatory caspases such as caspase-
1 and -11 (Franchi et al., 2012; Lamkanfi and Dixit, 2012; Rathi-
nam et al., 2012). Caspase activation can lead to proteolytic
maturation of cytokines interleukin (IL)-1b and IL-18 and elicit
the inflammatory form of cell death pyroptosis, as ways to con-
trol exogenous and endogenous invasions.
Inflammasomes are supramolecular assemblies composed of
at least a sensor protein and a caspase and often the adaptor
protein ASC. Based on the domain architecture of the sensor
protein, inflammasomes may be divided into two families. The
first family is known as ALR (Absent in Melanoma 2 [AIM2]-like
receptor), named after the first identified member (Figure 1A).
ALRs are composed of an N-terminal PYD and one or two HIN
domains (Rathinam et al., 2012). AIM2 directly senses the cyto-
solic PAMPs double-stranded DNAs (dsDNAs), such as those
associated with viruses, using its HIN domain (Jin et al., 2012;
Rathinam et al., 2012). The second class of inflammasomes con-
tains receptors in theNLR (nucleotide-binding domain [NBD] and
leucine rich repeat [LRR]-containing receptors) family (Figure 1A).
NBD belongs to the AAA+ superfamily of ATPase domains. Most
NLRs contain an N-terminal PYD and are known as NLRPs. The
best-studied NLRP3 inflammasome is activated following a wide
range of pathogen and danger signals, including extracellular
ATP and uric acid crystals (Franchi et al., 2012; Lamkanfi and
Dixit, 2012; Rathinam et al., 2012). Upon activation, both AIM2
and NLRP3 recruit the PYD- and CARD-containing bipartite
adaptor ASC (apoptosis-associated speck-like protein contain-
ing a CARD) through PYD/PYD interactions (Masumoto et al.,
1999). ASC, in turn, recruits caspase-1 through CARD/CARDCell 156, 1193–1206, March 13, 2014 ª2014 Elsevier Inc. 1193
Figure 1. AIM2 Promotes Formation of ASCPYD Filaments
(A) Domain composition and interaction hierarchy of NLRP3 and AIM2 inflammasomes.
(B) An electron micrograph of the AIM2PYD/ASCPYD binary complex.
(C) Gel filtration fractions of biotinylated AIM2PYD/ASCPYD complex as visualized by Coomassie-blue-stained SDS-PAGE (left) and streptavidin-alkaline phos-
phatase western blot (right). A lane between the marker and fraction samples on the SDS-PAGE was removed during figure preparation.
(D) Labeling of biotinylated AIM2PYD/ASCPYD binary complex by streptavidin-gold conjugate (6 nm).
(E) Fluorescence polarization (FP) assay of AIM2PYD-nucleated ASCPYD filament formation. mP, unit for FP. Data are represented as mean ± SD (n = 3).
(F) Effect of dsDNA on AIM2FL-nucleated ASCPYD filament formation. 2 mMof AIM2FL monomer from gel filtration was incubated with or without equimolar 300 bp
dsDNA (assuming a 10 bp footprint of AIM2 for molar calculation) for 30 min before diluting to a working concentration 0.1 mM (ASCPYD: AIM2FL = 10:1) for the FP
assay. Data are represented as mean ± SD (n = 3).
See also Figure S1.interactions (Figure 1A). PYD andCARDboth belong to the death
domain (DD) fold superfamily (Ferrao and Wu, 2012), for which
structures of two defined DD helical assemblies are known (Lin
et al., 2010; Park et al., 2007).
Malfunctioning of inflammasomes is associated with serious
human diseases (Strowig et al., 2012). Mutations in inflamma-
some proteins NLRP3, NLRP12, andMEFV (also known as Pyrin)
are linked to autoinflammatory and fever syndromes (Rathinam
et al., 2012). Aberrations in NLR inflammasome activation have1194 Cell 156, 1193–1206, March 13, 2014 ª2014 Elsevier Inc.been connected to psoriasis, type II diabetes, inflammatory
bowel diseases, and Alzheimer’s disease (Franchi et al., 2012;
Lamkanfi and Dixit, 2012; Rathinam et al., 2012; Strowig et al.,
2012). The PYD-less ALR member, mouse p202, interacts with
the HIN domain of AIM2 to inhibit inflammasome and potentiate
lupus (Yin et al., 2013).
Immunofluorescence microscopy showed that transfected
full-length ASC (ASCFL) and endogenous ASC upon stimula-
tion both form speck-like aggregates (Masumoto et al., 1999).
Because transfected PYD and CARD-only ASC fragments are
filamentous (Masumoto et al., 2001), the specks are most likely
dense, crosslinked composites of PYD and CARD filaments.
Because of the strong tendency of ASC to aggregate, the struc-
tures of ASC PYD (ASCPYD) and ASCFL were solved in mono-
meric states using nuclear magnetic resonance (NMR) at acidic
conditions (de Alba, 2009; Liepinsh et al., 2003). Although addi-
tional monomeric PYD structures have been reported, including
those of NLRP3 (Bae and Park, 2011) and AIM2 (Jin et al., 2013),
the mode of homo- and hetero-PYD associations is entirely
unknown.
Here, we used in vitro reconstitution, electron microscopy
(EM) and polymerization assays to address assembly mecha-
nisms for ASC-dependent AIM2 and NLRP3 inflammasomes.
In contrast to the presumption that the different domain struc-
tures of AIM2 and NLRP3 may lead to considerable differences
in the inflammasome architectures, we showed that both AIM2
upon dsDNA interaction and NLRP3 oligomerized through its
NBD nucleate ASCPYD filaments. This is particularly surprising
for NLRP3 due to the domain similarity of NLRs to Apaf-1-like
molecules that form ring-like platforms (Yuan and Akey, 2013).
The overarching paradigm had presumed that NLR inflamma-
somes are also ring-like structures. The flexibly linked ASC
CARD (ASCCARD) then clusters along the ASCPYD filament to
act as the platform for caspase-1CARD filament formation, lead-
ing to proximity-induced caspase dimerization and activation.
The ternary inflammasome complex showed star-shaped
branched filamentous morphology and exhibited unequal stoi-
chiometries among the component proteins. We determined
the cryoelectron microscopy (cryo-EM) structure of the ASCPYD
filament at near-atomic resolution through helical reconstruc-
tion. The structure revealedmolecular details of ASCPYD/ASCPYD
interactions and allowed modeling of AIM2PYD/ASCPYD and
NLRP3PYD/ASCPYD interactions. Structure-based mutagen-
esis confirmed the importance of ASCPYD/ASCPYD, AIM2PYD/
ASCPYD, and NLRP3PYD/ASCPYD interactions in vitro and in cells.
EM of immunoprecipitated endogenous NLRP3 inflammasome
showed similar filamentousmorphology as in-vitro-reconstituted
inflammasomes and quantitative western blotting confirmed the
overstoichiometry of caspase-1 to ASC. Our studies collectively
revealed a universal assembly process for ASC-dependent
inflammasomes in both ALR and NLR families that involves
nucleation-induced polymerization.
RESULTS
The AIM2PYD/ASCPYD Complex Is Filamentous with the
End Location of AIM2PYD
To elucidate the assembly mechanisms for ASC-containing
inflammasomes, we first reconstituted the interaction between
AIM2 and ASC. Coexpression of AIM2PYD with ASCPYD showed
that the complex eluted at the void position of a Superdex 200
gel filtration column (Figure S1A available online), suggesting
formation of large ‘‘aggregates.’’ We used EM to visualize the
negatively stained AIM2PYD/ASCPYD complex, which revealed
filaments with uniform diameters of 9 nm (Figure 1B).
AIM2PYD exists in substoichiometric molar ratio in the
AIM2PYD/ASCPYD complex (Figures S1A and 1C). To understandthis observation, we generated a construct of AIM2PYD capable
of enzymatic biotinylation during expression. Coexpression of
the AIM2PYD construct with ASCPYD generated a complex with
specific biotinylation of AIM2PYD, shown by streptavidin western
blotting (Figure 1C). Labeling biotinylated AIM2PYD by 6 nm
streptavidin-gold particles showed that AIM2PYD is localized at
one end of the filaments (Figure 1D). The number of bound
gold particles varies between one and several, consistent with
the ability of AIM2PYD to form filaments when expressed alone
(Figure S1B). In the presence of ASCPYD, AIM2PYD preferentially
associated with ASCPYD to generate short heterogeneous
AIM2PYD filaments in complex with much longer ASCPYD fila-
ments. In contrast, Ni-NTA-gold labeling of His-tagged ASCPYD
in the biotinylated AIM2PYD/ASCPYD complex showed uniform
distribution along the filaments (Figure S1C), confirming that
ASCPYD forms the main filament body.
AIM2PYD and the Full-Length AIM2/dsDNA Complex
Nucleate ASCPYD Filaments
The end labeling of AIM2PYD suggested its role as the nucleator
for directional polymerization of ASCPYD. To quantitatively
assess ASCPYD filament formation, we set up a fluorescence
polarization (FP) assay in vitro using a His-MBP-ASCPYD fusion
construct with an added C-terminal Cys for conjugating with
Alexa 488 fluorophore. The large fusion tag MBP inhibited
ASCPYD polymerization to enable His-MBP-ASCPYD to be ex-
pressed in the monomeric form (Figure S1D). Polymerization
of Alexa-488-labeled monomeric ASCPYD was initiated by addi-
tion of the TEV protease to remove His-MBP from the fusion
protein. The increase in FP, which indicates ASCPYD polymeri-
zation, was monitored as a function of time (Figure 1E). Although
ASCPYD did polymerize on its own upon His-MBP removal,
the rates of polymerization were dramatically enhanced in the
presence of increasing amounts of substoichiometric AIM2PYD
(1/16–1/2 molar ratios) (Figure 1E). The initial drop in FP corre-
sponded with His-MBP removal by TEV and the decrease
in size of ASCPYD. At 5 min after TEV addition, about 75%
His-MBP was removed from the fusion protein (Figure S1E).
The AIM2PYD/ASCPYD filaments generated from the polymeriza-
tion assay (Figure S1F) showed similar morphology to the coex-
pressed complex (Figure 1B).
Full-length AIM2 (AIM2FL) is a cytosolic dsDNA sensor in
which the interaction of its C-terminal HIN domain with dsDNA
induces ASC recruitment and inflammasome formation. The
PYD in AIM2 has been shown to interact with its HIN domain
to provide autoinhibition in the absence of dsDNA binding (Jin
et al., 2013). To reconstitute AIM2 inflammasome activation
in vitro, we expressed AIM2FL as a His-MBP fusion. Purified
His-MBP-AIM2FL was first incubated with equimolar 300 bp
dsDNA (molar ratio calculated based on 10 bp footprint of
AIM2 on dsDNA), followed by mixing with Alexa-488-labeled
His-MBP-ASCPYD. TEV was added to remove His-MBP to
initiate ASCPYD polymerization as monitored by FP (Figure 1F).
A dramatic increase in FP was observed upon activation of
AIM2FL by dsDNA, recapitulating the cellular event of inflamma-
some activation. These data suggest that overcome of autoinhi-
bition and oligomerization of AIM2 by dsDNAs are crucial for
inducing ASCPYD polymerization.Cell 156, 1193–1206, March 13, 2014 ª2014 Elsevier Inc. 1195
Figure 2. NLPR3FL and NLRP3PYD-NBD, but Not NLRP3PYD, Promote ASCPYD Filament Formation
(A–C) Nucleation of ASCPYD filaments by titrating increasing amounts of NLRP3PYD (A), NLRP3PYD-NBD (B), NLRP3FL (C) asmonitored by fluorescence polarization.
Data are represented as mean ± SD (n = 3).
(D) A less aggregated gel filtration fraction of NLRP3 was subjected to ASCPYD polymerization assay with or without 5 mM ATP. Data are represented as mean ±
SD (n = 3).
(E) Streptavidin-gold (6 nm) labeling of biotinylated NLRP3PYD-NBD/ASCPYD binary complex.
See also Figure S2.NLRP3PYD-NBD Nucleates and End Labels ASCPYD
Filaments
NLRs share similar domain architectures and are recognized to
be autoinhibited in the absence of suitable ligands. In NLRC4,
an NLR with a CARD, its LRR domain plays an important role
in inhibiting NLR oligomerization (Hu et al., 2013). Due to their
domain similarity to Apaf-1-like molecules that form ring-like
platforms through the NBDs to induce caspase activation and
apoptosis (Yuan and Akey, 2013), the overarching paradigm ap-
pears to presume that NLRP inflammasomes are also ring-like
structures organized by the NBD. Formation of filamentous
structures in the AIM2PYD/ASCPYD interaction prompted us to1196 Cell 156, 1193–1206, March 13, 2014 ª2014 Elsevier Inc.examine ASC-dependent NLRP inflammasomes using the pro-
totypical member NLRP3.
We expressed and purified NLRP3PYD, NLRP3PYD-NBD, and
NLRP3FL. Although AIM2PYD exists as filamentous oligo-
mers and was sufficient in promoting ASCPYD polymerization,
NLRP3PYD is a monomer and did not cause significant enhance-
ment in ASCPYD polymerization (Figure 2A). Both insect cell and
E. coli expressed NLRP3PYD-NBDwith inclusion of theNBD eluted
from the void position of a Superdex 200 gel filtration column and
induced greatly increased ASCPYD polymerization (Figure 2B).
In comparison, NLRP3PYD-NBD is a much stronger promoter
of ASCPYD polymerization than AIM2PYD; it caused significant
enhancement of ASCPYD polymerization at a low 1:1,600 molar
ratio (Figure 2B). Notably, under the physiological intracellular
condition of 140 mM KCl and 10 mM NaCl (pH 7.4) and a lower
ASC concentration, ASCPYD did not significantly polymerize
unless increasing amounts of NLRP3PYD-NBD were added (Fig-
ure S2A), suggesting that ASC does not polymerize under steady
physiological state without stimulation. The PYD of NLRP3 is
required for ASCPYD polymerization because NLRP3PYD-NBD
proteins withmutations on PYD are compromised in this function
(see below), suggesting that NBD-oligomerized NLRP3PYD forms
the platform for ASCPYD polymerization.
Insect-cell-expressed NLRP3FL showed a wide distribution
on a Superdex 200 gel filtration column (Figure S2B). In keeping
with autoinhibition in NLRP3FL as in NLRC4 (Hu et al., 2013), we
found that even the highly aggregated NLRP3FL showed less
activity than NLRP3PYD-NBD in promoting ASCPYD polymerization
because more molar quantities of NLRP3FL were required to
achieve similar degrees of FP enhancement (Figures 2B and
2C). Despite being activated by an extensive list of stimuli, it is
uncertain what constitutes the direct activator of NLRP3 (Rathi-
nam et al., 2012). We found that addition of ATP enhanced the
less aggregated fractions of recombinant NLRP3FL in activating
ASCPYD polymerization (Figure 2D); however, this activation is
minimal in comparison. It is likely that ATP binding by the NBD
is associated with, but not sufficient for, NLRP3 activation.
Induction of ASCPYD polymerization by NLRP3 suggests that
NLRP3 may reside at the end of ASCPYD filaments. We gener-
ated a His-MBP-NLRP3PYD-NBD construct capable of enzymatic
biotinylation during expression. We mixed purified His-MBP-
NLRP3PYD-NBD-Biotin with His-MBP-ASCPYD and added the
TEV protease to cleave off His-MBP to allow ASCPYD polymeri-
zation. The purified NLRP3-Biotin/ASC complex was subjected
to negative-stain EM and 6 nm streptavidin-gold labeling, which
confirmed localization of NLRP3 to the end of ASCPYD filaments
(Figure 2E). Using negative-stain EM, we showed that purified
NLRP3PYD-NBD is heterogeneous with a mixture of disk-like
structures and filaments (Figure S2C). The latter may represent
the spiral, lock washer-like mode of oligomerization of the NBD.
Cryoelectron Microscopy Structure of ASCPYD at Near-
Atomic Resolution
To generate a homogeneous population of ASCPYD filaments
without the AIM2 or NLRP3 nucleators, we used in vitro ASCPYD
polymerization starting from purified monomeric His-MBP-
ASCPYD (Figure S1D). Upon TEV treatment to cleave off His-
MBP, ASCPYD filaments spontaneously formed as shown by
cryo-EM (Figure 3A). Cryo-EM images were collected using
automated data acquisition on a Titan Krioswith a Falcon II direct
electron detector. Averaged power spectra of segments from
cryo-EM images of the helical filaments showed a strong merid-
ional reflection at 1/13.9 A˚1, which corresponds to the recip-
rocal of the axial rise but exhibited variable twist (Figures 3B
and 3C), like many other helical polymers (Egelman et al.,
1982). The magnitude of this variation can be seen in Movie S1.
Images were processed using the Iterative Helical Real Space
Reconstruction (IHRSR) method with a solid cylinder as the initial
reference (Egelman, 2000). The helical heterogeneity was dealt
with by sorting images by twist to generate a subset with similarhelical parameters, resulting in amap at6 A˚ resolution. Correc-
tion of out-of-plane tilt was applied to further improve the map to
a conservatively estimated resolution of 3.8 A˚, as determined
by both Fourier shell correlation (FSC) (Rosenthal and Hender-
son, 2003) (Figure S3A) and comparison with the final atomic
model (Figures S3B and S3C).
Rigid-body fitting of the NMR structure of ASCPYD (Liepinsh
et al., 2003) into the cryo-EM map generated a pseudo atomic
model of the ASCPYD filament. The fit of the NMR structure
resolved the enantiomorphic ambiguity in EM reconstructions,
but even without the NMR structure the hand of the a helices
in the reconstruction was clear, eliminating such ambiguities.
The rigid-body fit was followed by real-space refinement
(Schro¨der et al., 2007) to generate a final atomic model with
clearly defined side chain densities (Figures 3D, 3E, and S3D).
The ASCPYD filament is hollow with inner and outer diameters
of 20 and 90 A˚, respectively (Figure 4A). The polar filament
has a C3 point group symmetry with 53 right-handed rotation
and 14.0 A˚ axial rise per subunit, after correcting for a mean
out-of-plane tilt of 6.
The structure of ASCPYD in the filament exhibits conforma-
tional differences with that of ASCPYD alone (Figure 4B). This is
apparent in the highly variable a2-a3 loop and the short a3 helix,
with clear cryo-EM density (Figure S4A). PYDs share a unique
feature: the a3 helix is shortened or missing and follows the
long and flexible a2-a3 loop (Figure S4B). The conformational
changes are likely due to participation of this region in all three
types of interactions in the filament (see below and Figure S3D).
Although the ASCPYD alone structure was determined at a pH
below 4.0 (Liepinsh et al., 2003), lack of significant conforma-
tional differences elsewhere and absence of acidic residues in
a3 helix support the structural changes as due to filament forma-
tion. Among known PYD structures, NLRP3PYD and ASC2PYD
possess a conformation similar to the filament conformation of
ASCPYD (Figure 4C), suggesting that NLRP3PYD and ASC2PYD
may be better interactors with ASCPYD. The former similarity
may account for the high efficiency of NLRP3PYD-NBD in promot-
ing ASCPYD polymerization (Figure 2B). ASC2 is a PYD only pro-
tein that is highly homologous to ASCPYD and has been shown
to associate with ASC to modulate caspase-1 activation (Stehlik
et al., 2003). If ASC2 can be incorporated into ASCPYD filaments
but lacks the effector CARD, it could inhibit caspase-1 recruit-
ment and activation. One face of a cross-section of the filament
is largely negatively charged, whereas the opposite face is
largely positively charged (Figure 4D), suggesting the role of
charge complementarity in filament assembly.
Detailed Interactions in the ASCPYD Filament
There are three major asymmetric interfaces (types I, II, and III) in
the filament, one within each of the three-start helical strands
(type I), and two between the strands (types II and III) (Figure 4E).
Remarkably, despite being within the DD superfamily, the PYD/
PYD interactions show remarkable differences to the DD com-
plex structures (Figures 4F and S4C–S4E; Table S1). If one of
the subunits is aligned, the corresponding partner subunit would
need to rotate by 15–26, 21–35, and 18–52 for the type I, II,
and III interfaces, respectively, relative to the corresponding
interfaces in the MyD88/IRAK4/IRAK2 DD complex and theCell 156, 1193–1206, March 13, 2014 ª2014 Elsevier Inc. 1197
Figure 3. Cryo-EM Structure of the ASCPYD Filament at Near-Atomic Resolution
(A) A cryo-EM image of ASCPYD filaments.
(B) Average power spectra of ASCPYD filaments in two twist bins (left and right halves) showing constant axial rise per subunit (blue arrow) and variable long-range
twist features (red arrows).
(C) Filament segments can be divided into separate twist bins according to azimuth angle, or rotation per subunit.
(D) Cryo-EM reconstruction of the ASCPYD filament, superimposed with the final atomic model shown in three colors each for one start of the three-start helical
assembly.
(E) A zoom up view of helix a6 shown in stick model and superimposed with the EM density.
See also Figure S3 and Movie S1.PIDD/RAIDD DD complex (Ferrao andWu, 2012; Lin et al., 2010;
Park et al., 2007) (Figures S4C–S4E; Table S1). Relatively, the
structural superposition indicates that the type I interaction is
the most conserved, which is also the most dominant, burying
about 880 A˚2 of surface area. Type II and III interactions are
highly variable and bury 540 and 360 A˚2 of surface area, respec-
tively. Structural differences between PYD and other members
of the DD fold superfamily and formation of a substantial central
cavity may have shifted the relative orientations of the subunits in
the type I, II, and III interactions.
In the previously observed DD/DD interactions, type I is medi-
ated by residues at a1 and a4 (type Ia) and residues at a2 and a3
(type Ib) (Ferrao andWu, 2012; Lin et al., 2010; Park et al., 2007).
Despite being themost conserved, the relative shift in orientation
and the structural differences between DDs and PYDsminimized
the involvement of a3 in the intrastrand type I PYD/PYD interac-
tion (Figures 4G and S3D). In the interstrand type II PYD/PYD1198 Cell 156, 1193–1206, March 13, 2014 ª2014 Elsevier Inc.interaction, residues at the a4-a5 corner of one ASCPYD (type
IIa) and residues at the a5-a6 corner of the second ASCPYD
(type IIb) mediate this interaction (Figures 4H and S3D). In the
interstrand type III PYD/PYD interaction, a2-a3 corner of one
ASCPYD (type IIIa) interacts with the a1-a2 corner (type IIIb) of
the other subunit (Figures 4I and S3D). Prominently, the PYD-
unique and highly variable a2-a3 loop participates in all three
types of PYD/PYD interactions (Figure S3D), which may explain
the conformational changes in this region upon filament forma-
tion (Figure 4B). Overall the interactions contain charged, hydro-
philic, and hydrophobic components, with charge interactions
playing an important role (Figures S4F–S4H). Consistently,
ASCPYD polymerization exhibits salt dependence (Figure S4I).
Structure-Based Mutagenesis In Vitro and in Cells
Structure-guided mutagenesis in vitro confirmed the role of type
I, II, and III interactions in ASCPYD filament formation, as shown
Figure 4. Detailed Cryo-EM Model of the ASCPYD Filament
(A) The ASCPYD filament is a three-start helical assembly with C3 symmetry as shown in a surface representation. The three-start helical strands are denoted by
red, cyan, and yellow, respectively, with alternating darker and lighter shades to show subunit boundaries.
(B) Comparison of the initial ASCPYD subunit model (gray, PDB ID 1UCP) and the subunit structure after refinement against the cryo-EM density (cyan).
(C) Structures of ASC2PYD (magenta) and NLRP3PYD (orange) are similar to the ASCPYD subunit structure in the filament (cyan).
(D) Electrostatic surface representations of approximate cross-sections of the filament.
(E) A schematic diagram of the ASCPYD filament and the three types of asymmetric interactions, defined in accordance with the previously observed DD/DD
interactions.
(F) Comparison of the type III interactions in the ASCPYD filament (cyan) and in the MyD88/IRAK4/IRAK2 DD complex (orange).
(G–I) Detailed interactions in type I, II, and III interfaces, respectively. Side chains of interfacial residues are shown as stick models and labeled.
See also Figure S4.
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Figure 5. Structure-Based Mutations Disrupt ASCPYD Filament Formation, AIM2PYD/ASCPYD Interaction, and NLRP3PYD/ASCPYD Interaction
In Vitro and in Cells
(A) Size-exclusion chromatography of WT and mutant ASCPYD showing both filamentous (void) and monomeric fractions from a Superdex 200 column. Hyphen
denotes ASCPYD and asterisk denotes a contaminant.
(B) Morphology of transfected WT and mutant eGFP-tagged ASCPYD constructs visualized by confocal laser scanning microscopy. The arrowhead depicts
filaments. n, nucleus; scale bars = 10 mm.
(C) Morphology of transfected eGFP-tagged ASCPYD visualized by confocal laser scanning microscopy. Top: ASCPYD with charge reversal mutation on a residue
outside thefilament interface.Bottom:ASCPYDwith triple-charge reversalmutation that rescued thedefectivenessof the singlemutants.Arrowheadsdepict filaments.
(D) A schematic model of AIM2PYD/ASCPYD or NLRP3PYD/ASCPYD filaments composed of a top AIM2PYD or NLRP3PYD layer extended by ASCPYD filament body.
(E and F) Mutations of conserved interfacial residues on AIM2PYD (E) and NLRP3PYD-NBD (F) reduced or abolished their ability to nucleate ASCPYD filaments.
See also Figure S5.by elution in more monomeric fractions (Figure 5A). In particular,
K21Q, K21E/K22E, K26E, R41E, D48R, D48N, and D51R of the
type I interface, F59E of the type II interface, and E13R and
R41E of the type III interface abolished filament formation (Fig-
ure 5A; Table S2). Additional mutations, R3E and L50A of the
type I interface, and Y36A and E80R of the type II interface,
weakened filament formation as shown by increased presence
in the monomeric fractions in comparison with the wild-type
(WT) (Figure 5A; Table S2). Mutations that disrupted filament for-1200 Cell 156, 1193–1206, March 13, 2014 ª2014 Elsevier Inc.mation in vitro also abrogated the ability of eGFP-ASCPYD to form
filaments in cells as shown by confocal and fluorescence micro-
scopy (Figures 5B, S5A, and S5B) and by EM of immunopurified
samples (Figures S5C and S5D). A previous extensive mutagen-
esis study on surface-exposed charged residues confirmed the
importance of additional observed interfacial residues in ASCPYD
filament formation in cells (Moriya et al., 2005) (Table S2).
In contrast to disruptive phenotypes of mutations on interfa-
cial residues, the charge reversal mutation E67R outside the
interface did not affect eGFP-ASCPYD filament formation (Fig-
ure 5C). At the type I interface, K21, D48, and D51 interact with
each other (Figure 4G), and mutations on each of the residues
disrupt filament formation (Figures 5A and 5B). Remarkably,
the triple-charge reversal mutant K21E/D48K/D51K rescued
eGFP-ASCPYD filament formation in cells (Figure 5C), supporting
the validity of the structurally observed interactions.
Modeled AIM2PYD/ASCPYD and NLRP3PYD-NBD/ASCPYD
Interactions
The ASCPYD filament structure provides a template for modeling
the AIM2PYD/ASCPYD and NLRP3PYD/ASCPYD hetero-PYD/PYD
interactions using the published crystal structures of AIM2PYD
(Jin et al., 2013) and NLRP3PYD (Bae and Park, 2011). End loca-
tions of AIM2PYD and NLRP3PYD in their complexes with ASCPYD
filaments suggest that the PYDs in AIM2 andNLRP3 continue the
helical arrangement seen in the ASCPYD filament using a combi-
nation of the same type I, II, and III interactions (Figure 5D). Given
the observed conformational changes at the a2-a3 corner, which
points down in the helical diagram (Figure 4D), we reasoned that
AIM2 andNLRP3 PYDs should reside above the ASCPYD filament
(Figure 5D).
We selected residues in AIM2PYD and NLRP3PYD structures
corresponding to those in ASCPYD that caused impairment in
filament formation when mutated (Figures 5A and 5B). Assaying
the ability of AIM2PYD and NLRP3PYD-NBD mutants in promoting
ASCPYD polymerization showed that mutations on each of the
predicted interfaces in AIM2PYD, including L10A/L11A, R24E
and F27G of the type I interface, Y74R of the type II interface,
and G38E, K39E, and D15R of the type III interface, either abol-
ished or showed greatly reduced promotion of ASCPYD polymer-
ization (Figure 5E; Table S3). Additionally, in a recently published
study on AIM2PYD, the D19A/E20A/E21A/D23A mutation, which
harborsmostly type I interface residues, abolished the interaction
with ASCPYD (Jin et al., 2013). Similarly, mutations at each of the
predicted type I, II, and III interfacial residues on NLRP3PYD,
including K23E/K24E and M27E of the type I interface, E64R
and D82R of the type II interface, and R43W and E15R of
the type III interface, caused almost complete impairment in pro-
moting ASCPYD polymerization by the NLRP3PYD-NBD construct
(Figure 5F; Table S3). It should be noted because AIM2PYD also
aggregates into similar filaments (Figure S1B), the same muta-
tions would likely affect both AIM2/ASC interaction and AIM2
self-association. For NLRP3, the PYD does not self-associate,
whereas the NBD mediates self-association; therefore, the PYD
mutations inNLRP3woulddirectly affect ASC interaction.Collec-
tively, these data support that the interactions in the ASCPYD
filament also define the mode of hetero-oligomerization in the
AIM2PYD/ASCPYD and NLRP3PYD/ASCPYD interaction pairs.
Reconstitution of the Ternary AIM2 Inflammasome
The C termini of ASCPYD subunits extend prominently outward
from the filament (Figure 6A), providing a connection to
the CARD in ASC after a 23-residue linker. Superposition of
the NMR structure of ASCFL (de Alba, 2009) with ASCPYD in the
filament displayed the flexibly linked, peripheral ASCCARD (Fig-
ure 6B). To reveal the structural architecture of full ternary inflam-
masomes, we expressed and purified His-GFP-caspase-1CARD,His-MBP-ASCFL, and His-MBP-AIM2PYD. We mixed the three
proteins with the TEV protease to allow His-MBP removal and
formation of a ternary complex. His-tag pull-down showed that
His-GFP-caspase-1CARD interacted with ASCFL and AIM2PYD
(Figure 6C). The stoichiometry between ASCFL and AIM2PYD in
the ternary complex is consistent with that in the AIM2PYD/
ASCPYD binary complex with AIM2PYD under stoichiometric
(Figure 1C). ASC, in turn, appeared under stoichiometric to cas-
pase-1. EM showed that the ternary complex is star shaped
(Figure 6D). Anti-ASC immunogold labeling (15 nm) showed
that ASC resides in the center of the stars (Figure 6D). In contrast,
Ni-NTA conjugated with 6 nm gold particles labeled His-GFP-
caspase-1CARD along the arms of the stars (Figure 6E). These
data suggest that AIM2PYD nucleates short filaments of ASCFL
through PYD/PYD interactions and ASCCARD further initiates
caspase-1CARD filaments to promote caspase-1 activation.
Because the linker between ASC PYD and CARD is flexible,
the outer CARDs should be able to cluster together and act as
the platform for caspase-1 polymerization (Figure 6B).
We tested the role of ASCCARD in inflammasome assem-
bly using a caspase-1CARD polymerization assay. We used
‘‘sandwich’’-tagged His-MBP-caspase-1CARD-Sumo construct
becauseN-terminally taggedHis-MBP-caspase-1CARDconstruct
still formed filaments. A sortase motif was added for fluorophore
labeling (Theile et al., 2013). Polymerization of caspase-1CARD
was initiated by addition of TEV to cleave off His-MBP and moni-
tored by fluorescence polarization. In the presence ASCFL or
ASCCARDat substoichiometric ratios, caspase-1CARDpolymeriza-
tion was greatly enhanced (Figure 6F), consistent with nucleation
of caspase-1 polymerization by ASC.
It is intriguing that the ASCFL component in the ternary com-
plex does not display as long filaments as it does in the binary
AIM2PYD/ASCPYD or NLRP3PYD-NBD/ASCPYD complexes. We
reasoned that because His-MBP-ASCFL forms bundled clusters
minutes after removal of the His-MBP tag (Figure S6A) and pre-
cipitates, likely due to the CARD and its potential to crosslink fil-
aments, ASCFL might only exist as short filaments such that
almost all ASCCARD molecules are in complex with caspase-
1CARD. To determine whether the same ASCPYD interactions in
the observed filament govern those in the context of ASCFL,
we cotransfected Myc-His-tagged ASCFL with WT and mutant
ASCPYD-eGFP in 293T cells. Immunoprecipitated with anti-His
antibody followed by anti-eGFP western showed that Myc-His-
ASCFL pulled down WT ASCPYD-eGFP, but was severely
impaired in interacting with ASCPYD-eGFP that harbors muta-
tions on residues important for the ASCPYD filament formation
(Figures 6G and S6B). We further tested the effects of PYD
mutations in ASCFL using the in vitro inflammasome reconstitu-
tion assay. His-GFP-caspase-1CARD pulled down AIM2PYD in
the presence of WT ASCFL, but not mutant ASCFL defective in
formation of PYD filaments (Figure S6C), demonstrating that
the same interactions in the PYD filaments govern the interaction
in the ternary inflammasome complex.
Morphology and Stoichiometry of Endogenous NLRP3
Inflammasome
Our data suggest a unified model of inflammasome assembly in
which AIM2 upon dsDNA interaction or NLRP3 upon activationCell 156, 1193–1206, March 13, 2014 ª2014 Elsevier Inc. 1201
Figure 6. Reconstitution of the Full Ternary AIM2 Inflammasome
(A) The ASCPYD filament structure in a ribbon representation. The protruding C termini for connecting to ASCCARD are labeled for the subunits at the right.
(B) ASCFL NMR structure (PDB ID 2KN6) is superimposed on the ASCPYD model to show the outward located ASCCARD.
(C) Pull-down of the core AIM2 inflammasome in vitro as visualized on Coomassie-blue-stained SDS-PAGE.
(D and E) Electron micrographs of His-GFP-caspase-1CARD/ASCFL/AIM2PYD ternary complex labeled with anti-ASC gold (D) and Ni-NTA gold (E).
(F) Promotion of His-MBP-caspase-1CARD-Sumo (3 mM) polymerization by ASCFL or ASCCARD at substoichiometric ratios of 1:20 and 1:10 upon removal of
His-MBP by TEV. ASCPYD did not enhance caspase-1CARD polymerization.
(legend continued on next page)
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nucleates ASC helical clusters through PYD/PYD interactions
(Figure 6H). The oligomerized ASC CARDs then form the plat-
form for caspase-1CARD to nucleate into filaments, which, in
turn, bring caspase domains into proximity for dimerization,
trans-autocleavage, and activation (Figure 6H). To elucidate
the morphology of endogenous inflammasomes, we stimulated
THP-1 cells with uric acid crystals, immunoprecipitated the acti-
vated NLRP3 inflammasome using anti-ASC antibody, and sub-
jected the immunoprecipitated sample to negative-stain EM. The
images contained both single filaments (Figure 7A) and inter-
twined filaments (Figure S7A); the former resembles subcom-
plexes of in-vitro-reconstituted inflammasomes, and the latter
resembles clustered, ball-of-yarn-like reconstituted inflamma-
somes that form upon overnight incubation (Figure S7B).
It has been shown previously that, upon stimulation, each cell
forms one gigantic NLRP3 punctum adjacent to the nucleus (Fer-
nandes-Alnemri et al., 2007). To visualize the structure of such
a punctum in situ, we expressed ASC-eGFP in COS-1 cells
and performed immunogold EM on ultrathin cryosections that
preserve native structures. Control cells transfected with eGFP
alone showed neither punctum nor anti-ASC gold labeling, and
ASC-eGFP-transfected cells did not exhibit gold labeling in the
absence of the anti-ASC primary antibody (Figure S7C). Specific
gold labeling was shown in ASC-eGFP-transfected cells in the
presence of anti-ASC primary antibody and protein A-gold
(10 nm) treatment (Figure 7B). The labeling revealed a densely
packed perinuclear punctum of about 2 mm in size, in contrast
to the hollow structure implicated previously (Masumoto et al.,
1999). The dense structures are consistent with the ball-of-
yarn-like architectures of in-vitro-reconstituted and in-cell-
immunoprecipitated inflammasomes.
In vitro reconstitution of the ternary inflammasome suggests
an overstoichiometry of caspase-1 to ASC (Figure 6C). To
determine whether endogenous ASC-dependent inflamma-
somes from cells also possess the similar property, we stimu-
lated THP-1 cells with uric acid crystals, immunoprecipitated
the activated NLRP3 inflammasome using anti-ASC antibody,
and performed quantitative western blotting using recombinant
caspase-1 and ASC as standards. These experiments showed
that caspase-1 is overstoichiometric to ASC, by 3.5-fold in
the current experiment (Figures 7C, 7D, S7D, and S7E). It should
be noted that an anti-ASC antibody would have precipitated
both ASC alone and its complex with caspase-1, and there-
fore, the measured 3.5-fold overstoichiometry should be an
underestimation.
Structure-Guided PYD Mutations Compromise IL-1b
Processing
Onemain biological consequence of inflammasome activation is
the processing of pro-IL-1b by caspase-1 to IL-1b. To address
the consequence of structure-based mutations in biological(G) Mutations in ASCPYD reduced its binding to ASCFL. ASCFL-Myc-His was cotran
blotting was carried out using anti-His and anti-eGFP antibodies, respectively.
(H) Model of inflammasome assembly. Upstream sensing proteins such as AIM2 a
ASC filament assembly through PYD/PYD interactions. Multiple ASCCARD mole
interactions. Proximity induced dimerization of the caspase domain activates the
See also Figure S6.function, we used a cotransfection strategy to assay IL-1b pro-
cessing (Jin et al., 2012). Cotransfection of caspase-1, pro-IL-
1b, and ASC did not cause significant cleavage of pro-IL-1b
into mature IL-1b (Figure 7E). Although addition of WT AIM2
activated the inflammasome and led to IL-1b production,
cotransfection of PYD-interaction-defective AIM2 mutants
compromised IL-1b conversion (Figure 7E), demonstrating the
functional consequence of observed PYD/PYD interactions.
DISCUSSION
A Near-Atomic Resolution Structure by Cryo-EM
Our reconstruction of a small, structurally variable biological
sample represents a significant advance in high-resolution struc-
ture determination by cryo-EM, made possible by automated
microscopy (Potter et al., 1999), a state-of-the-art electron mi-
croscope (the Titan Krios), and a new generation of direct elec-
tron detectors (Bai et al., 2013; Bammes et al., 2012; Li et al.,
2013; Liao et al., 2013), combined with existing computational
approaches for variable twist polymers (Egelman, 2000; Egel-
man et al., 1982). Most of the structures that have been currently
solved by cryo-EM to near-atomic resolution are icosahedral
viruses that are highly ordered and with a high degree of internal
symmetry (Zhou, 2011). In the absence of any mechanism to
maintain long-range order, all biological polymers will display
cumulative disorder (Egelman and DeRosier, 1982). We think
that the new hardware and software advances in cryo-EM will
have an enormous impact in allowing many biological polymers,
including thosewhose helical symmetry could not even be deter-
mined with confidence, to now be reconstructed at near-atomic
resolution.
PYD/PYD Interactions
The ASCPYD filament structure presented here provides insights
into molecular mechanisms of homo- and hetero-PYD associa-
tions in inflammasomes. Among the PYDs with known struc-
tures, NLRP3, NLRP12, AIM2, and ASC2 have been shown to
interact with ASC (Rathinam et al., 2012; Stehlik et al., 2003).
Consistently, they exhibit the highest sequence conservation at
the ASC-interaction surfaces with 61%, 54%, 50%, and 89%
homology, respectively (Table S4). The ASCPYD structure may
also provide a template for other PYDs with no structures such
as the IFI16PYD filament cooperatively assembled on dsDNA
(Morrone et al., 2013).
A number of mutations in NLRP3, NLRP12, and MEFV have
been shown to associate with hereditary periodic fever syn-
dromes. For NLRP3, all mutations are dominant and likely cause
activation by overcoming autoinhibition (Touitou et al., 2004). For
NLRP12, a nonsense mutation and a splicing defect generate
truncated proteins at residues 284 and 646, respectively, and
cause spontaneous inflammation (Je´ru et al., 2008), suggestingsfected withWT andmutant ASCPYD-eGFP. Immunoprecipitation and western
nd NLRP3 oligomerize upon activation to form a platform of PYDs that induces
cules cluster to promote caspase-1 filament formation through CARD/CARD
enzyme followed by autocleavage.
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Figure 7. Morphology, Stoichiometry, and Pro-IL-1b Processing in Inflammasomes
(A) Morphology of anti-ASC-immunoprecipitated NLRP3 inflammasomes from uric-acid-crystal-activated THP-1 cells analyzed by negative-stain EM. Arrows
denote filaments.
(B) Immunogold EM on ultrathin cryosections from ASCFL-eGFP-transfected COS-1 cells. The ASC-containing compact structure is densely decorated by gold
particles (10 nm). N, nucleus; NM, nuclear membrane.
(C and D) Quantification of immunoprecipitated ASC-containing complex (IP) from uric-acid-crystal-activated THP-1 cells using quantitative anti-ASC (C) and
anti-caspase-1 p12 (D) western blotting. Known amounts of recombinant His-MBP-ASC and His-GFP-caspase-1 were western blotted to generate standard
curves. The full-length caspase-1 and the cleaved p12 bands were both included in the quantification. The asterisk denotes IgG.
(E) AIM2 inflammasome reconstitution in HEK293T cells to define the functional consequence of structure-based mutations in AIM2. Cells were cotransfected
with plasmids encoding pro-IL-1b and caspase-1 (lane 1), plus ASC alone (lane 2), orWT AIM2 alone (lane 11), or ASC together withWT or indicated AIM2mutants
(lanes 3–10). Maturation of pro-IL-1b into biologically active IL-1b was detected by western blotting using anti-iL-1b antibody (top). The expression levels of
HA-ASC and Flag-AIM2 were detected by western blotting using anti-HA and anti-Flag antibodies (bottom).
See also Figure S7.that the PYD and part of the NBD are sufficient for inflammasome
formation and activation. For MEFV, hundreds of variants, most
of which are associated with Familial Mediterranean Fever
(FMF), have been identified (Touitou et al., 2004). Gene insertion
‘‘knockin’’ (KI) mouse models with three frequent FMF-associ-
ated mutations (M680I, M694V, and V726A) showed that they1204 Cell 156, 1193–1206, March 13, 2014 ª2014 Elsevier Inc.caused severe spontaneous inflammatory phenotypes (Chae
et al., 2011). Most relevant to the PYD interactions, six mutants,
T12I, Y19C, K25R, R39G, E84K, and A89T, have been mapped
to the PYD ofMEFV (Touitou et al., 2004). None of these residues
directly map to the PYD/PYD interaction surfaces (Figure S3D)
and may therefore act by overcoming autoinhibition.
A Unified Assembly Mechanism for Inflammasomes
Our data here present a mechanism for the assembly of ASC-
dependent inflammasomes, in which AIM2 and NLRP3 both
nucleate helical ASC clusters through PYD/PYD interactions,
and ASC, in turn, nucleates caspase-1 filaments through
CARD/CARD interactions (Figure 6H). These minimal structures
coalesce to form the micron-sized, dense structures we
observed in situ. We propose that CARD-containing NLRs
(NLRCs), which are independent of ASC, may also form filamen-
tous structures by directly promoting caspase-1 polymerization
through CARD/CARD interactions. Therefore, the mechanism of
nucleation-induced filament formationmay extend beyond ASC-
dependent inflammasomes. It has been shown that uncleaved
caspase-1 catalytic domain forms dimers in crystals (Elliott
et al., 2009); this dimerization may occur within caspase-1 fila-
ments in inflammasomes, resulting in intradimer cleavage, stabi-
lization of dimerization, and enhancement of enzymatic activity.
Recent studies have revealed that in many innate immune
pathways, multiple intracellular signaling proteins assemble
into higher-order signalingmachines for transmission of receptor
activation information to cellular responses, with implicated new
molecular mechanisms for threshold behavior, time delay of acti-
vation, and temporal and spatial control of signal transduction
(Wu, 2013). Here, we show that inflammasomes also assemble
into higher-order signalosomes that likely impart similar proper-
ties to its activation and kinetics. In this scenario, upon reaching
the NLRP3 or AIM2 activation threshold, caspase-1 may poly-
merize until its concentrations falls below the dissociation con-
stant. Given that caspase-1 is overstoichiometric to ASC by
just a few fold, the average lengths of individual ASC-nucleated
caspase-1 filaments in cells may be shorter than those reconsti-
tuted in vitro, leading to punctate, rather than filamentous
morphology of intact inflammasomes. Once formed, inflamma-
somesmay require active processes such as autophagy for their
degradation (Saitoh et al., 2008). This scenario is reminiscent of
the case for the filamentous CARMA1/Bcl10/MALT1 signalo-
some (Qiao et al., 2013) andmay represent a general mechanism
of disassembly of higher-order signalosomes in innate immunity
to terminate signaling.
EXPERIMENTAL PROCEDURES
Recombinant Protein Expression and Purification
Various His-, His-MBP-, and His-MBP-Sumo ‘‘sandwich’’-tag fusion con-
structs or coexpression constructs of AIM2, ASC, caspase-1, and NLRP3
were expressed in E. coli and insect cells. Biotinylation was performed in
E. coil by coexpression with biotin ligase. All mutations in this construct
were introduced using the QuikChange mutagenesis protocol.
Polymerization Assays
His-MBP-ASCPYD and His-MBP-caspase-1CARD-Sumo were labeled with
Alexa 488 and TAMRA fluorophores, respectively. Filament formation was
monitored using fluorescence polarization upon addition of TEV protease to
remove His-MBP, in the presence and absence of various nucleators of
polymerization.
Nanogold and Immunogold EM
Standard protocols were used for streptavidin-gold labeling of biotinylated
proteins, Ni-NTA-nanogold labeling of His-tagged proteins, and immunogold
labeling by appropriate antibodies using negative-stain EM. ASC-transfectedCOS-1 cells were pelleted, fixed, flash frozen, and ultrathin sectioned for
immunogold EM and contrasting with uranyl acetate.
Cryo-EM, Image Processing, and Refinement
Grids containing ASCPYD were imaged using an FEI Titan Krios electron
microscope operating at 300 keV, and recorded using a 4k 3 4k Falcon II
direct electron detector with a backthinned CMOS chip. The images were
processed with SPIDER (Frank et al., 1996), and the IHRSR algorithm (Egel-
man, 2000) was used for helical reconstruction. The ASCPYD NMR structure
(Protein Data Bank [PDB] ID 1UCP) (Liepinsh et al., 2003) was chosen as the
starting model and the refinement was carried out using DireX (Schro¨der
et al., 2007). We estimate the resolution of the reconstruction at 3.8 A˚ as
determined by both Fourier shell correlation and comparison with the final
atomic model.
AIM2 Inflammasome Reconstitution
HEK293T cells were transfected with pEFBOS-C-term-Guassia luciferase/
Flag pro-IL-1b (54 kDa), procaspase-1, HA-ASC, and the full-length wild-
type or mutant Flag-AIM2 expression constructs using GeneJuice (Novagen).
Cell lysates were probed with mouse anti-iL-1bmonoclonal antibody. Expres-
sion of ASC and AIM2 was detected using anti-Flag and anti-HA antibodies,
respectively. See also Extended Experimental Procedures.
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The cryo-EM map of ASCPYD filament was deposited in EMDataBank under
accession code EMD-5830. The corresponding refined structure of ASCPYD
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